» Articles » PMID: 21163694

Performance of a Rapid Antigen Test (Binax NOW® RSV) for Diagnosis of Respiratory Syncytial Virus Compared with Real-time Polymerase Chain Reaction in a Pediatric Population

Overview
Journal J Clin Virol
Specialty Microbiology
Date 2010 Dec 18
PMID 21163694
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Infants from Alaska's Yukon-Kuskokwim Delta (YKD) have a high respiratory syncytial virus (RSV) hospitalization rate (104/1000/yr). Appropriate patient management requires rapid and accurate RSV diagnosis. Antigen-based methods are often used in clinical settings, but these tests can lack sensitivity.

Objective: We compared Binax NOW(®) RSV (BN) used for RSV diagnosis in the YKD hospital with a real-time polymerase chain reaction assay (RT-qPCR) used for viral surveillance.

Study Design: Between October 2005 and September 2007 we obtained nasopharyngeal washes (NPW) from children <3 years hospitalized with a lower respiratory tract infection. The NPW were tested using BN and RT-qPCR.

Results: 79/311 (25%) children had RSV infection as determined by RT-qPCR. As compared with RT-qPCR, sensitivity and specificity of BN were 72% and 97%, respectively. The sensitivity of BN was higher in children <1 year compared with children ≥ 1 year (79% vs. 52%; p=0.025), children with bronchiolitis compared with children without bronchiolitis (89% vs. 38%; p<0.001), and children with a shorter duration of symptoms before testing (0-1 (92%) vs. 2-4 (78%) vs. 5+ (65%) days; p=0.04). The median RSV viral load in NPW positive by BN and RT-qPCR was 1.01 × 10(9)copies/mL vs. a median of 5.25 × 10(7)copies/mL for NPW positive by RT-qPCR only (p<0.001).

Conclusion: RT-qPCR is more sensitive than BN in detecting RSV infection. BN sensitivity is high in children with bronchiolitis, but the sensitivity is low when children present with a non-bronchiolitis illness, especially after a longer duration of symptoms before testing.

Citing Articles

Clinical performance of two commercially available rapid antigen tests for influenza, RSV, and SARS-CoV-2 diagnostics.

Savolainen L, Peltola J, Hilla R, Aman T, Broas M, Junttila I Microbiol Spectr. 2024; 13(1):e0163024.

PMID: 39589150 PMC: 11705943. DOI: 10.1128/spectrum.01630-24.


Rapid testing for respiratory syncytial virus in a resource-limited paediatric intensive care setting.

Newman H, Tshabalala D, Mabunda S, Nkosi N, Carelson C Afr J Lab Med. 2024; 9(1):1084.

PMID: 38361787 PMC: 10867673. DOI: 10.4102/ajlm.v9i1.1084.


Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age.

Movva N, Suh M, Bylsma L, Fryzek J, Nelson C J Infect Dis. 2022; 226(Suppl 2):S213-S224.

PMID: 35968874 PMC: 9377029. DOI: 10.1093/infdis/jiac203.


Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era.

Bernstein D, Mejias A, Rath B, Woods C, Deeter J J Appl Lab Med. 2022; 8(2):353-371.

PMID: 35854475 PMC: 9384538. DOI: 10.1093/jalm/jfac058.


Clinical Performance of the AllplexTM Respiratory Panel 1 Test Compared to SimplexaTM Flu A/B and RSV for Detection of Influenza Virus and Respiratory Syncytial Virus Infection Including Their Subtyping.

Kim J, Nam J, Jang W, Lim C Med Princ Pract. 2019; 28(4):380-386.

PMID: 30831570 PMC: 6639576. DOI: 10.1159/000499313.